Investors are funding a high-growth company, we expect them to use our money to accelerate growth. Expectations of cash flow positive and short term worries about cash resources are contrary and unhelpful to accelerating growth. We can't have it both ways, we either grow the asset as fast as possible increasing the wealth of all shareholders, or we cap the asset growth and suck out the profits. I vote for growth, and awesomely that's what the company is delivering, growth exceeding expectations.![]()
- Forums
- ASX - By Stock
- CL8
- September 2015 Quarter Trading Update
September 2015 Quarter Trading Update, page-14
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CL8 (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.488M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 92826 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 101771 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 92826 | 0.012 |
2 | 922816 | 0.011 |
6 | 950000 | 0.010 |
1 | 120000 | 0.008 |
1 | 200000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 101771 | 1 |
0.018 | 850000 | 3 |
0.019 | 503399 | 1 |
0.020 | 1980000 | 4 |
0.028 | 400000 | 1 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
CL8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online